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Mutations in the GBA gene encod-ing glucocerebrosidase cause Gau-
cher disease (GD), the most prevalent of 
the lysosomal storage disorders (LSDs) 
and increase susceptibility to Parkinson 
disease (PD). Clinically the two disor-
ders can present in a similar manner with 
analogous pathological features, sug-
gesting mechanistic links between the 
two disease states. An increasing body 
of evidence implicates defects in quality 
control pathways in both, and suggests 
that LSDs, as a group, can be classed as 
disorders of autophagy. Using a mouse 
model of type II neuronopathic GD, we 
observed global defects in cellular qual-
ity control pathways in midbrain neurons 
and astrocytes. Our data suggest that 
downregulation of autophagy, mitoph-
agy, and the ubiquitin-proteasome system 
(UPS) results in accumulation of dys-
functional and fragmented mitochondria, 
insoluble SNCA/α-synuclein deposits 
and ubiquitinated proteins. These obser-
vations show that dysfunction of cellular 
quality control pathways lead to impaired 
energy and free radical homeostasis, pro-
viding new insights into the mechanisms 
of neurodegeneration in GD and illumi-
nating the links between GD and PD.
Gaucher disease is a rare inborn error 
of metabolism. It is the most common 
of the LSDs and is caused by recessive 
mutations in the GBA gene, resulting 
in decreased lysosomal function due to 
the accumulation of substrate (glucocer-
ebroside). Located within the lysosome, 
GBA is responsible for hydrolysis of its 
substrate into glucose and ceramide. GD 
can be classed into three subsets based 
on age of onset and the presence of cen-
tral nervous system abnormalities. Type I 
(OMIM#230800) is the most common 
and is defined by the absence of cen-
tral nervous system irregularities. Type 
II (OMIM#230900) is classed as acute 
neuronopathic GD and presents with 
severe neurological defects including sei-
zures in early childhood, whereas type 
III (OMIM#2301000) is chronic, with a 
late onset neurodegenerative phenotype. 
Whereas type I is currently treatable with 
enzyme replacement therapy, there is no 
equivalent treatment for types II and III, 
as the recombinant enzyme as does cross 
the blood-brain barrier.
The neurological and pathological 
symptoms observed in type I GD patients 
are similar to those displayed in Parkinson 
disease, including loss of dopaminergic 
neurons in the substantia nigra, SNCA 
accumulation, tremors at rest, bradyki-
nesia, and rigidity. Indeed, parkinsonism 
has been reported in many GD patients, 
suggesting a mechanistic link between 
the two disease states. Further support-
ing this, large, multicenter genome-wide 
association studies have reported a high 
incidence of GBA mutations in patients 
with sporadic PD and an increased risk 
of developing PD in GBA carriers. While 
the molecular mechanism underlying GD 
pathology is poorly defined, the primary 
defect is thought to be lysosomal, due to 
glucocerebroside accumulation. As the 
lysosome is central to the autophagy pro-
cess, much attention has been given to the 
possible role of autophagy in progression 
of the disease.
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Using an aggressive mouse model of 
type II neuronopathic GD we found that 
cellular quality control mechanisms are 
defective, associated with an inability 
to turn over the damaged pool of mito-
chondria in midbrain neurons and astro-
cytes. As lysosomal function is required 
for fusion with the autophagosome, this 
step fails in type II GD due to an accu-
mulation of substrate (Fig. 1). Indeed, 
the autophagic pathway is downregu-
lated as evidenced by reductions in both 
LC3-I and LC3-II as well as conjugated 
ATG12–ATG5 (at the protein, not the 
mRNA level). Using a GFP-LC3 reporter, 
we found that LC3-I was unable to be 
converted to LC3-II, possibly due to the 
lack of phagophore membranes, presum-
ably preventing conjugation to phos-
phatidylethanolamine, while autophagic 
flux was severely reduced. As autophagy 
is blocked, SQSTM1/p62 accumulates 
and impinges on the UPS with reduced 
proteasome activity and accumulation of 
ubiquitinated proteins, specifically those 
modified at lysine-48. Insoluble SNCA 
oligomers fail to be degraded, accumu-
late and form deposits in the midbrain 
(Fig. 1). The neurodegenerative pathology 
here is seen as early as one day postnatal 
in the mouse brain, and these animal die 
within 2 weeks of birth.
As mitochondrial dysfunction has 
long been associated with PD, we inves-
tigated whether this was also a feature of 
GD. The largely fragmented mitochon-
drial population has a reduced membrane 
potential (ΔΨ
m
) that is maintained by the 
reversal of the F
1
F
o
-ATPase (complex V). 
This phenomenon has also been reported 
in neurons in which the PD-associated 
protein PINK1 is depleted, as this is a 
compensatory mitochondrial mechanism 
that prevents dissipation of ΔΨ
m
. Mito-
chondrial-derived reactive oxygen species 
(ROS) have long been implicated in the 
pathology of neurodegenerative disorders 
and are generated by a damaged respira-
tory chain, primarily at complex I (CI) and 
to a lesser extent complex III. Exposure of 
cells to the mitochondrially targeted anti-
oxidant MitoQ
10
 partially rescues ΔΨ
m
, 
suggesting the mitochondrial dysfunc-
tion observed in this model of GD may 
be amplified by a feedback cycle involving 
damage to the respiratory chain by ROS 
generated at CI.
As mutations in the PARK family of 
proteins impair mitophagy (mitochondrial 
specific autophagy) and are associated with 
Figure 1. Defective proteostasis in gD stems from impaired autophagy. this has an impact upon the upS and mitophagy as well as turnover of aggre-
gated SncA oligomers. this results in a toxic build-up of damaged proteins and organelles leading to neuronal cell death. glccr, glucocerebroside.
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familial PD, we investigated whether the 
defective mitochondrial pool was “marked” 
for turnover via the PINK1-PARK2 path-
way. In spite of the reduced ΔΨ
m
, PARK2 
translocation is not observed, suggesting 
that reversal of the ATPase maintains ΔΨ
m
 
above the threshold required for PINK1-
mediated PARK2 recruitment, thus ensur-
ing that damaged mitochondria are not 
marked for turnover via mitophagy. This 
suggests that the inherent mitochondrial 
compensatory mechanism, reversal of the 
ATPase, may contribute to the overall 
pathophysiology in GD.
Overall similar mechanisms appear to 
engage in the pathophysiology of both 
GD and PD, with defects in cellular 
quality control pathways playing central 
roles in both disease states. The observa-
tion of accumulated dysfunctional mito-
chondria in GD (and PD) highlights 
the importance of appropriate turnover 
of this organelle, as failure results in the 
breakdown of normal energy homeosta-
sis as this indispensible organelle become 
destructive, leaking ROS and potentially 
activating the intrinsic apoptotic path-
way. Taken together, global defects in 
proteostasis may underpin the neurode-
generative aspects of both GD and PD. In 
the end, a pathogenic threshold is crossed 
as a result of a toxic build-up of misfolded 
and ubiquitinated protein aggregates 
(including SNCA) ultimately resulting in 
neuronal death.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were 
disclosed.
